Suppr超能文献

[韦格纳肉芽肿病过程中快速进展性肾小球肾炎1例]

[A case of rapidly progressive glomerulonephritis in the course of Wegener's granulomatosis].

作者信息

Idasiak-Piechocka I, Oko A, Łochyńska K, Woźniak A, Czekalski S

机构信息

Klinika Nefrologii Akademii Medycznej w Poznaniu.

出版信息

Pol Arch Med Wewn. 2000 Mar-Apr;103(3-4):195-200.

Abstract

Wegener's granulomatosis (WG) is characterized by granulomatous vasculitis of the respiratory tract and glomerulonephritis (GN). Prognosis of this disease is poor and about 20% of untreated patients die after one year from the onset. WG was recognized in 45-year-old patient on the basis of: 1) clinical symptoms (joint pain and swollen, purpura on the skin which appeared one week after respiratory tract infection, ulceration of the tonsils and lingula), 2) results of additional testing (X-chest-ray-infiltrates of both lungs), positive results of the cANCA (titre 1:640) and rapidly progressive renal failure [the increase of serum creatinine level (Pcr) from 123.7 to 707 mumol/l (1.4 to 8.0 mg/dl) during one week]. Renal biopsy revealed extracapillary GN (cellular crescents in 7 out of 8 glomeruli and scattered foci of fibrinoid necrosis of capillary walls in all). At the beginning of the treatment Pcr raised to 884 mumol/l (10 mg/dl) and the patient required hemodialysis. He was treated with methylprednisolone (M) at flash doses of 1000 mg/24 h by three days followed by 125 mg/24 h i.v.--because of peptic ulcer, with cyclophosphamide (C-150 mg/24 h p.p.), with trimetoprim/sulphametoxazole, with pentoxifylline and omeprazol. After six weeks of the treatment in the control kidney biopsy sclerotic changes in 10 out of 13 glomeruli and diffuse interstitial fibrosis were found. However, during the same time, we observed clinical remission of the disease and the decrease of Pcr to 176.8 mumol/l (2 mg/dl). The M dosis was reduced by 5 mg every weeks and the C dosis--to 50 mg (because of the increase of aminotransferase levels) After six months of the treatment Pcr was 132.6 mumol/l (1.5 mg/dl) and CANCA titer was 1:16. In this case of RPGN, despite off the progression of the morphological changes in the kidney, we obtained the clinical remission of the disease and significant decrease of Pcr level. These results suggest that aggressive treatment of WG is justified even in patients with advanced renal failure requiring dialysis and in such patients clinical remission is possible to occur.

摘要

韦格纳肉芽肿病(WG)的特征是呼吸道肉芽肿性血管炎和肾小球肾炎(GN)。这种疾病的预后很差,约20%未经治疗的患者在发病后一年内死亡。一名45岁患者被诊断为WG,依据如下:1)临床症状(关节疼痛和肿胀、呼吸道感染一周后出现的皮肤紫癜、扁桃体和舌部溃疡);2)其他检查结果(胸部X线显示双肺浸润)、抗中性粒细胞胞浆抗体(cANCA)阳性(滴度1:640)以及快速进展性肾衰竭[血清肌酐水平(Pcr)在一周内从123.7升至707μmol/L(1.4至8.0mg/dl)]。肾活检显示为毛细血管外增生性GN(8个肾小球中有7个出现细胞性新月体,所有肾小球均有散在的毛细血管壁纤维蛋白样坏死灶)。治疗开始时Pcr升至884μmol/L(10mg/dl),患者需要血液透析。因其患有消化性溃疡,给予甲泼尼龙(M)冲击剂量1000mg/24小时,连用三天,随后静脉滴注125mg/24小时,同时给予环磷酰胺(C - 150mg/24小时口服)、甲氧苄啶/磺胺甲恶唑、己酮可可碱和奥美拉唑。治疗六周后,肾活检显示13个肾小球中有1个出现硬化改变,伴有弥漫性间质纤维化。然而,与此同时,我们观察到疾病临床缓解,Pcr降至176.8μmol/L(2mg/dl)。M剂量每周减少5mg,C剂量减至50mg(因转氨酶水平升高)。治疗六个月后,Pcr为132.6μmol/L(1.5mg/dl),cANCA滴度为1:16。在这个快速进展性肾小球肾炎(RPGN)病例中,尽管肾脏形态学改变仍在进展,但我们实现了疾病的临床缓解以及Pcr水平的显著下降。这些结果表明,即使对于需要透析的晚期肾衰竭患者,积极治疗WG也是合理的,且此类患者有可能实现临床缓解。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验